INTRODUCTION
============

The family of Src kinases play key roles in the signal transduction of many cell surface receptors in a diverse range of cellular functions, such as cell growth, differentiation, migration, and survival ([@B7]; [@B52]). In T cells, the lymphocyte-specific protein tyrosine kinase (Lck) is critical in the early propagation and modulation of T cell receptor (TCR) signaling. TCR signaling is triggered by the recognition and engagement of antigenic peptides bound to major histocompatibility complex (MHC) and relies on the phosphorylation by Lck of receptor complex at immunoreceptor tyrosine-based activation motif (ITAM) consensus sites. Phosphorylated ITAMs recruit zeta-chain-associated protein kinase 70 (Zap70), which requires additional phosphorylation by Lck to be activated ([@B72]; [@B51]). Zap70 in turn phosphorylates other proteins in TCR signaling cascade, which eventually leads to T cell activation.

Lck is bound to the plasma membrane via myristoylated and palmitoylated residues at its N-terminus. It also contains a SH3 and a SH2 domains next to the membrane anchor followed by a catalytic tyrosine kinase domain and a short C-terminal tail. As an essential kinase in the propagation of TCR signaling, the regulation of Lck activity is itself tightly controlled by conformational changes mainly relying on phosphorylation and dephosphorylation on two regulatory tyrosine residues. When the C-terminal inhibitory tyrosine (Tyr505) is phosphorylated, it can interact with its own SH2 domain, which causes an intra-molecular arrangement and locks the kinase in an inactive or "closed" conformation (**Figure [1](#F1){ref-type="fig"}**). SH3 and SH2 domains intra molecular interactions also contribute to stabilize the closed conformation ([@B3]). In contrast, phosphorylation of the activating tyrosine (Tyr394) stabilizes the activation loop in an active conformation ([@B77]; [@B3]). An intermediary form in which Lck is phosphorylated on both regulatory tyrosine residues also exists and is catalytically active. This double phosphorylated form accounts for \~20% of all Lck in T lymphocyte ([@B13]; [@B49]). The inhibitory Tyr505 residue is phosphorylated by C-terminal Src kinase (Csk) and dephosphorylated by the tyrosine phosphatase CD45 ([@B1]; [@B51]). The activating Tyr394 residue is phosphorylated by Lck in a process of transphosphorylation. Tyr394 is also dephosphorylated by SH2 domain-containing phosphatase-1 (SHP-1; [@B66]) and CD45, which can hence positively and negatively regulate Lck activity ([@B1]; [@B60]). Currently the consensus is that CD45 acts predominately negatively on Lck activity ([@B13]; [@B74]) because high levels of CD45 are required to dephosphorylate Y394 while low levels are sufficient for Y505 dephosphorylation and Lck activation ([@B44]; [@B80]). This suggests that Lck is kept inactive by high level of CD45 in resting cells, whereas partial segregation of the two molecules upon TCR activation reduces the levels of CD45 and favors dephosphorylation at Y505 and hence Lck activation. All in all, the various combinations of kinases and phosphatase accounts for the complex regulatory mechanism of Lck (**Figure [1](#F1){ref-type="fig"}**).

![**Interactions controlling Lck localization upon TCR activation.** In resting cells, Lck is located in microdomains where it interacts directly with CD45 that acts both on activating Tyr394 and inhibiting Tyr505. Csk is targeted to membrane microdomains by PAG and aids to limit Lck activity *via* Tyr505 phosphorylation. Association with membrane domains and protein--protein interactions prevent constitutively active Lck to phosphorylate TCR or Zap70 in resting cells. Upon activation, CD45 is excluded from membrane microdomains and Csk detaches from the plasma membrane as a consequence of PAG dephosphorylation by CD45. Lck oligomerizes, binds to and phosphorylates TCR and Zap70 to mediate TCR signaling. Interactions with TSAd and CD4/8 contribute to enhance TCR binding and signaling.](fimmu-03-00167-g001){#F1}

In resting T lymphocytes, a large percentage of Lck is constitutively active. More surprisingly, however, TCR activation has no impact on Lck activity with the proportion of the different phosphorylation and conformational states of Lck remaining relatively unchanged ([@B63]; [@B53]; [@B49]). This implies that a pool of constitutively active Lck is responsible for the propagation of TCR signaling. Lck activity is thought to be held in check under resting conditions by phosphatases and Csk. Consequently, suppression of phosphatases activity by pervanadate treatment markedly enhances phosphorylation of Y394 and promotes T cell activation ([@B63]). Similarly, inhibiting Csk activity triggers phosphorylation of Lck at Tyr394 and TCR signaling ([@B62]). Taken together, it seems that Lck kinase activity and TCR phosphorylation are critically regulated by the interaction probabilities of kinases, phosphatases, and their substrates.

SPATIAL PATTERNING OF THE IMMUNOLOGICAL SYNAPSE
===============================================

Since the binding of TCR to antigenic peptides does not increase the proportion of active Lck, the mechanisms that allow the kinase to initiate signaling only when the receptor is peptide-bound are likely to depend on interaction probabilities and hence spatial distributions within the plasma membrane of Lck relative to its modulators and targets. In this model, ITAM phosphorylation is balanced by the access of constitutively active Lck to TCRs relative to the action of phosphatases. To characterize the spatial patterns of signaling proteins at T cell activation sites and immunological synapses and identify the mechanisms of the lateral membrane organization has therefore been a long-standing goal of many researchers.

When stimulated with antigen presenting cells, TCR and signaling proteins redistribute to first form so-called TCR microclusters ([@B64]) and then the bull-eye pattern of a mature immunological synapse ([@B25]; [@B16]). The diffusion of Lck molecules within the plasma membrane is indeed affected by TCR activation: Lck molecules display heterogeneous diffusion in activated cells with an increased residency time in microdomains that contain TCR ([@B29]; [@B14]). Lck distribution matches that of TCR in activated cells, and both molecules are recruited simultaneously to the immunological synapse upon activation ([@B19]) where they co-localize in the center of the synapse ([@B45]; [@B22]). However, active Lck is found at the periphery of the immunological synapse, where it initiates TCR phosphorylation and signaling cascades ([@B8]). Interestingly, TCR clusters form before and independently of Lck ([@B8]) suggesting that Lck is somehow recruited to pre-formed TCR clusters. Importantly, CD45 and Lck have distinct and mutually exclusive localizations in activated T cells, consistent with the notion that upon TCR triggering, CD45 mainly limits Lck activity and TCR phosphorylation ([@B13]; [@B44]; [@B74]). Several studies report CD45 exclusion from TCR-containing areas within the immunological synapse ([@B30]; [@B37]) and more precisely from TCR microclusters ([@B69]; [@B33]). Additionally, CD45 is excluded from CD2 clusters that contain Lck and the adaptor linker for activation of T cells (LAT; [@B14]). Similarly, Csk loses its membrane association upon T cell activation, segregating *de facto* from membrane-associated Lck ([@B6]; [@B11]). In summary, the distribution of Lck is modified by TCR engagement, resulting in the recruitment of Lck to TCR microclusters and segregation of Lck from CD45 and Csk. However, the molecular mechanisms of these redistributions are poorly understood. Below, we discuss the interactions that may regulate Lck localization and distribution.

INTERACTIONS GOVERNING Lck LOCALIZATION AND DISTRIBUTION
========================================================

The first described mechanism that controls Lck localization is the binding of Lck to the coreceptors CD4 and CD8. Lck directly associate with CD4 and CD8 in T cells ([@B58]; [@B71]) -- an interaction that is mediated by zinc, which allows the cytoplasmic tails of CD4/8 to interact with the N-terminal region of Lck and to form heterodimers ([@B41]; [@B35]). The major function of CD4/8 is to enhance the recruitment of Lck to the immunological synapse ([@B27]) and deliver Lck to the TCR--pMHC complex ([@B39]; [@B70]; [@B2]). However, the TCR complex was able to induce signaling even the absence of coreceptors ([@B42]; [@B61]; [@B70]), emphasizing a role for CD4/8 mediated-delivery of Lck in enhancing specificity of TCR binding to pMHC rather than being a prerequisite for TCR signaling.

Protein--protein interactions play a dominant role in membrane distributions since such interactions regulate diffusion and often result in immobile clusters. The SH2 domain of Lck, which is essential for TCR signaling, is a mediator of such protein interactions (**Table [1](#T1){ref-type="table"}**). In the inactive conformation, the SH2 domain of Lck binds to the inhibitory phosphotyrosine (pTyr505) of Lck, preventing interactions with other proteins ([@B17]; [@B76]). However, the affinity of the SH2 domain for pTyr505 is relatively weak ([@B50]) allowing competitive binding with other proteins such as TCR and Zap70 ([@B15]; [@B67]; [@B78]). Interestingly, it is the phosphotyrosine binding property of the SH2 domain that mediates the interactions with the phosphorylated ζ chain of TCR and phosphorylated Zap70 ([@B38]). Thus, the SH2 domain can maintain a stable association of Lck with its main targets after they have been phosphorylated, effectively consolidating the protein network for sustained signaling and signal amplification ([@B54]). After TCR engagement, oligomerization of Lck, driven by a "head-to-toe" SH2 and SH3 domains association ([@B36]) likely contributes to the amplification of TCR signaling. However, to which extend specific SH2 interactions are essential or could substitute CD4/8 coreceptor engagement is currently not clear. The SH2 domains may also confer intrinsic adaptor properties to Lck, as a potential kinase independent function ([@B75]).

###### 

Lck molecular interactions.

  Interacting with   Lck part involved   Type of interaction    Effect onTCR signaling   Reference
  ------------------ ------------------- ---------------------- ------------------------ ------------------------
  CD4/8              N-terminus          Zinc mediated          Enhanced                 [@B41], [@B35]
  Zap70              SH2                 SH2--pTyr              Enhanced                 [@B15], [@B67], [@B78]
  TCRζ               SH2                 SH2--pTyr              Enhanced                 [@B67]
  pZap70, pTCRζ      SH2                 SH2--pTyr              Enhanced                 [@B38]
  Lck                SH2, SH3            SH2--SH3               Enhanced                 [@B36]
  CD45               SH2                 pTry independent SH2   Decreased                [@B47]
  Csk                pTyr394             SH2--pTyr              Decreased                [@B4]
  LIME               SH2                 SH2--pTyr              Decreased                [@B5], [@B28]
  TSAd               SH2                 SH2--pTyr              Increased                [@B43], [@B26]
  LAT                Unknown             Charges mediated       Decreased                [@B32]

SH2 domain interactions not only regulate Lck access to TCR and Zap70, but also take part in the control of Lck distribution relative to proteins that regulate its activity (**Table [1](#T1){ref-type="table"}**). A phosphotyrosine-independent interaction mediates the binding of Lck's SH2 domain to CD45 ([@B47]). Additionally, the SH2 domain of Csk binds to activating pTyr394 in Lck ([@B4]), probably preventing Lck hyperactivation. Lck and Csk interact indirectly as well, via SH2 mediated binding to the adaptor LIME ([@B5]; [@B28]). The SH2 domains of Lck also bind to the T cell-specific adapter protein (TSAd) that in turn positively regulates Lck activity upon TCR activation ([@B43]; [@B26]). Hence, the SH2 domain of Lck does not only contribute to the enhancement and propagation of TCR signaling, but also participate in regulating Lck activity by linking it to CD45 Csk and TSAd. Additionally, direct interaction of CD45 with CD3ζ ITAM domains may contribute to the differential localization and interaction of Lck and CD45 in resting and activated cells ([@B23]).

Other SH2 domain-independent protein--protein interactions also play a role in controlling Lck distribution. The diffusion and localization of membrane proteins including Lck can also be regulated by the actin cytoskeleton. Actin polymerization is essential in the formation of TCR microclusters, but is not required for their maintenance once they are established ([@B8]; [@B64]; [@B33]). Lck associates with actin upon TCR engagement, and is responsible for the SH2 domain-dependant anchoring of TCRζ to the actin cytoskeleton ([@B57]). However, more evidence is required to understand how Lck distribution is regulated by the actin cytoskeleton. Other protein--protein interactions of Lck with effectors include binding to LAT, which is recruited and phosphorylated by Zap70 and interacts with the active form of Lck upon TCR stimulation. Lck interaction with LAT is electrostatic and impacts negatively on Lck activity ([@B32]). Finally, extracellular protein--protein interactions can also act on Lck distribution: a lattice formed by galectin, a glycoprotein binding protein, can contribute to maintain Lck and CD45 in the common membrane microdomains in resting cells, favoring Lck inhibition by CD45 ([@B9]).

It has previously suggested that residency in membrane microdomains or lipid rafts controls Lck distribution relative to effectors and targets. The myristoylation and palmitoylation of Lck's membrane binding domain target the kinase to cholesterol- and glycolipid-enriched microdomains ([@B65]; [@B20]; [@B55]). These membrane microdomains are thought to aid the translocation of Lck to the immunological synapse after activation by antigen presenting cells ([@B31]). More specifically, active Lck translocates to lipid rafts upon TCR engagement ([@B20]). Such membrane compartmentalization is especially important for the regulation of Lck distributions relative to CD45 and Csk, thereby governing Lck activation status (**Figure [1](#F1){ref-type="fig"}**). Indeed, replacing the membrane targeting motif of Lck with that of Fyn results in aberrant TCR signaling ([@B59]) and hyper-phosphorylation of the inhibitory Tyr505 ([@B24]). However, even though TCR activation reduces CD45 association with lipid rafts ([@B18]), the evidence whether CD45 and Lck localization in the same microdomains favors or prevents Lck activation is confusing ([@B56]; [@B10]). PAG/Cbp is a raft-associated membrane protein that interacts with Csk and localizes the kinase to lipid rafts in resting cells ([@B6]; [@B34]) where it contributes to Lck inhibition by phosphorylating the inhibitory Tyr505. Upon T cell activation, PAG is dephosphorylated and Csk is removed from the plasma membrane to allow Lck activation ([@B6]; [@B11]). Other evidence for the importance of lipid domains comes from coreceptors: CD28 induces the recruitment of Lck to lipid rafts ([@B68]), where Lck associates with CD4, which in turn controls raft aggregation ([@B21]). However, the controversy about methodologies used lipid raft studies ([@B46]) and the questions about their very existence ([@B48]) as well as the fact that CD45 can either activate and deactivate Lck ([@B60]) prevent a clear understanding of the lipid rafts role in the control of Lck distribution. In a landmark study, [@B14] have shown that the membrane anchor of Lck that targets the proteins to lipid raft does not control Lck diffusion and microclusters localization. Although membrane lipid composition is likely to be involved in the control of Lck distribution, it could be *via* other mechanisms, such as the electrostatic effects of the charges-mediated binding of TCRζ chain basic residues to the plasma membrane, which controls TCR--Lck interactions and hence localizations ([@B79]). It should also be noted that spatial control of Lck distribution can be achieved without proteins or lipids interactions as proposed by the kinetic-segregation model. This model postulates that close-contacts zones are created when engaged TCR shorten the distance between T cell and APC membranes. CD45 that bears a large ectodomain is excluded from these areas, generating a favorable environment for TCR and Zap70 phosphorylation by Lck ([@B12]).

CONCLUSION
==========

Since Lck is constitutively active and TCR engagement does not modulate Lck activity *per se*, it is thought that the spatial distributions of Lck relative to its substrates and other kinases and phosphatases minimize ITAM phosphorylation in resting T cells while fast and efficiently phosphorylating the receptor in activated cells. Evidence has been presented for various mechanisms that may regulate Lck localizations in the plasma membrane such as SH2 domain-mediated interactions with TCR signaling proteins and Lck activity-regulating proteins, SH2 domain-independent scaffolding functions, association with lipid rafts and redistribution caused by the close contact zone between cellular membranes. It is very likely that Lck localization is regulated by the same processes that allow the formation of compositionally distinct TCR microclusters and synapse patterns upon TCR triggering. New single-molecule fluorescence microscopy methods that measure protein distributions with nanometer precision may afford new insights into protein distributions during T cellactivation ([@B40]; [@B73]) that allow us to determine the interdependencies between Lck activity, conformational states and TCR phosphorylation.
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